MacroGenics
MGNX
MGNX
135 hedge funds and large institutions have $375M invested in MacroGenics in 2022 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 41 increasing their positions, 48 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
1.35% less ownership
Funds ownership: 93.58% → 92.23% (-1.3%)
15% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 48
Holders
135
Holding in Top 10
–
Calls
$360K
Puts
$388K
Top Buyers
| 1 | +$11.1M | |
| 2 | +$3.44M | |
| 3 | +$2.06M | |
| 4 |
BlackRock
New York
|
+$1.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.76M |
Top Sellers
| 1 | -$4.93M | |
| 2 | -$4.41M | |
| 3 | -$2.89M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.78M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$2.43M |